Interim survey results
Scientists have recently developed a technology called CRISPR-Cas9, which enables scientists to cut and paste DNA within the genome. The tool permits genetic engineering on an unprecedented scale and at a very low cost. The technique is already being used in a variety of fields, but because of its potential to modify DNA in human embryos, it has prompted calls for a public debate about where the technology should be applied.
Researchers working with WhatIsBiotechnology are running a pilot survey to gather people's views on this new technology. Dr Lara Marks, Managing Editor of the site and historian of medicine and Dr Silvia Camporesi, bioethicist at King's College London, are leading the project.
To date the survey has attracted feedback from 559 respondents and 1725 individual comments. This page contains a summary of the interim feedback from respondents. Please note that as more people join the debate these charts may change. The analysis is broken down into four pages: the respondent's agreement or disagreement with seven statements about CRISPR-Cas9, their comments, keywords and phrases used to describe the technology and finally the respondents profile. Use the inline links or the links above to navigate between these pages.
As these are interim results the survey is still open for people to submit their views. Click here if you would like to take part in the debate. If you have any questions about this survey please contact Dr Camporesi on email@example.com.
Haven't joined the debate yet? Click here to participate!
Follow us to keep up with all the new content about the world of biotechnology.